Randall Moreadith is CSO at Serina Therapeutics, Inc. (SER). They have made 35 open-market trades across 1 company since 2025, most recently 2026-03-23.
CIK 0001301120
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 35 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| SER | 6,500 | $13K |
Shares reported on the most recent Form 4, priced at the 2026-03-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| SER | SELL | 2026-03-23 | 2026-03-24 | $2.86 | $19K | -14.3% | -22.2% | -22.6% |
| SER | SELL | 2026-03-19 | 2026-03-20 | $2.50 | $98K | -22.9% | -22.9% | -21.0% |
| SER | SELL | 2026-02-02 | 2026-02-03 | $1.53 | $20K | -38.4% | -47.1% | -35.7% |
| SER | SELL | 2026-01-28 | 2026-01-29 | $1.80 | $23K | -39.1% | -48.7% | -47.8% |
| SER | SELL | 2026-01-22 | 2026-01-23 | $2.95 | $7K | +1.4% | -43.9% | -30.0% |
| SER | SELL | 2026-01-20 | 2026-01-21 | $2.03 | $12K | -5.6% | -43.8% | -29.5% |
| SER | SELL | 2026-01-13 | 2026-01-14 | $2.50 | $16K | +1.5% | -32.2% | -27.8% |
| SER | SELL | 2026-01-08 | 2026-01-09 | $2.69 | $35K | +22.3% | -7.0% | -17.8% |
| SER | SELL | 2025-12-23 | 2025-12-29 | $2.60 | $11K | +9.5% | +17.2% | -20.9% |
| SER | SELL | 2025-12-22 | 2025-12-23 | $2.67 | $15K | -18.1% | +16.5% | +20.1% |
| SER | SELL | 2025-12-16 | 2025-12-17 | $2.96 | $10K | -30.7% | +6.9% | -53.8% |
| SER | SELL | 2025-12-12 | 2025-12-16 | $3.26 | $6K | -23.1% | -10.0% | -51.5% |
| SER | SELL | 2025-12-11 | 2025-12-12 | $3.24 | $12K | -22.4% | -21.5% | -50.4% |
| SER | SELL | 2025-12-09 | 2025-12-11 | $3.33 | $4K | -22.2% | -23.8% | -53.7% |
| SER | SELL | 2025-12-02 | 2025-12-04 | $3.61 | $23K | -17.3% | -41.1% | -52.7% |
| SER | SELL | 2025-11-25 | 2025-11-26 | $3.90 | $23K | -15.3% | -32.0% | -57.3% |
| SER | SELL | 2025-11-24 | 2025-11-25 | $3.94 | $2K | -16.2% | -32.8% | -60.4% |
| SER | SELL | 2025-11-18 | 2025-11-19 | $3.75 | $24K | -1.6% | -28.9% | -57.4% |
| SER | SELL | 2025-11-10 | 2025-11-12 | $4.10 | $27K | -4.8% | -20.8% | -46.7% |
| SER | SELL | 2025-11-05 | 2025-11-06 | $4.24 | $14K | -9.6% | -20.2% | -31.7% |
| SER | SELL | 2025-11-04 | 2025-11-05 | $4.40 | $14K | -11.6% | -24.8% | -36.1% |
| SER | SELL | 2025-10-28 | 2025-10-29 | $4.96 | $28K | -16.9% | -11.3% | -42.9% |
| SER | SELL | 2025-10-27 | 2025-10-28 | $5.19 | $5K | -22.3% | -15.3% | -45.9% |
| SER | SELL | 2025-10-20 | 2025-10-21 | $4.97 | $32K | +2.0% | -23.3% | -41.4% |
| SER | SELL | 2025-10-13 | 2025-10-14 | $5.20 | $22K | +2.9% | -23.3% | -51.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.